NYSE:BXC BlueLinx Q1 2025 Earnings Report $71.42 -0.19 (-0.26%) Closing price 04/23/2025 03:59 PM EasternExtended Trading$71.50 +0.08 (+0.11%) As of 04/23/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Earnings HistoryForecast BlueLinx EPS ResultsActual EPSN/AConsensus EPS $0.32Beat/MissN/AOne Year Ago EPSN/ABlueLinx Revenue ResultsActual RevenueN/AExpected Revenue$717.50 millionBeat/MissN/AYoY Revenue GrowthN/ABlueLinx Announcement DetailsQuarterQ1 2025Date4/29/2025TimeAfter Market ClosesConference Call DateWednesday, April 30, 2025Conference Call Time10:00AM ETConference Call ResourcesEarnings HistoryCompany Profile BlueLinx Earnings HeadlinesBlueLinx to Host First Quarter 2025 Results Conference Call and Webcast on April 30, 2025April 16, 2025 | gurufocus.comLoop Capital Issues Pessimistic Forecast for BlueLinx (NYSE:BXC) Stock PriceApril 16, 2025 | americanbankingnews.comTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.April 24, 2025 | Porter & Company (Ad)BlueLinx price target lowered to $115 from $120 at Loop CapitalApril 15, 2025 | markets.businessinsider.comEstimating The Fair Value Of BlueLinx Holdings Inc. (NYSE:BXC)February 28, 2025 | finance.yahoo.comBluelinx Holdings (BXC) Gets a Buy from Benchmark Co.February 21, 2025 | markets.businessinsider.comSee More BlueLinx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BlueLinx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BlueLinx and other key companies, straight to your email. Email Address About BlueLinxBlueLinx (NYSE:BXC), together with its subsidiaries, engages in the distribution of residential and commercial building products in the United States. It distributes specialty products, including engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products; and structural products, such as lumber, plywood, oriented strand boards, rebars and remesh, as well as other wood products that are used for structural support in construction projects. It also provides various value-added services and solutions to customers and suppliers. The company serves national home centers, pro dealers, cooperatives, specialty distributors, regional and local dealers, and industrial manufacturers. BlueLinx Holdings Inc. was incorporated in 2004 and is headquartered in Marietta, Georgia.View BlueLinx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InCan IBM’s Q1 Earnings Spark a Breakout for the Stock?Genuine Parts: Solid Earnings But Economic Uncertainties RemainBreaking Down Taiwan Semiconductor's Earnings and Future UpsideArcher Aviation Unveils NYC Network Ahead of Key Earnings Report Upcoming Earnings AbbVie (4/25/2025)AON (4/25/2025)Colgate-Palmolive (4/25/2025)HCA Healthcare (4/25/2025)NatWest Group (4/25/2025)Cadence Design Systems (4/28/2025)Welltower (4/28/2025)Waste Management (4/28/2025)AstraZeneca (4/29/2025)Booking (4/29/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
